{"title":"微创胃癌远端胃切除术后Billroth-I和Roux-en-Y重建的临床结果比较:多中心回顾性倾向评分匹配分析","authors":"Yuma Ebihara, Noriaki Kyogoku, Hironobu Takano, Hideyuki Wada, Takeo Nitta, Daisuke Saikawa, Yoshiyuki Yamamura, Minoru Takada, Toshiaki Shichinohe, Satoshi Hirano","doi":"10.1097/SLE.0000000000001411","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Gastric cancer (GC) is the third leading cause of cancer deaths, with surgery as the primary treatment; however, the outcomes of different types of surgeries still need to be understood further. This study evaluated the surgical outcomes and prognosis after minimally invasive distal gastrectomy (MIDG) for GC in a multicenter retrospective cohort using propensity score matching.</p><p><strong>Methods: </strong>This study retrospectively enrolled 688 patients who underwent curative MIDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into Billroth-I reconstruction (B-I) and Roux-en-Y (R-Y) reconstruction groups. Propensity score matching was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Surgical outcomes and prognoses were compared.</p><p><strong>Results: </strong>Three hundred propensity score-matched pairs were identified. The R-Y group had longer median operation time [309 (131 to 531) min vs. 265 (126 to 532) min; P<0.001], longer postoperative hospital stay [10 (5 to 110) d vs. 10 (5 to 43) d; P=0.042], and greater median blood loss (P=0.047) than the B-I group. Complications of Clavien-Dindo (CD) grade II (P<0.001) and grade III (P=0.027) were more frequent in the R-Y group than in the B-I group. Five-year overall survival (OS) was significantly higher in the B-I group than in the R-Y group (91.1% vs. 83.4%; P=0.019), whereas 5-year relapse-free survival (RFS) showed no significant difference between these 2 groups (P=0.056). Independent prognostic factors included reconstruction method, postoperative complications (≥CD III), and lymph node metastasis (pN) for OS and age (≥80), pT, and pN for RFS.</p><p><strong>Conclusions: </strong>Patients who underwent R-Y reconstruction had more frequent postoperative complications than those who underwent B-I reconstruction after MIDG. Although not significantly associated with RFS, these complications may affect OS. The findings of this study could help develop strategies for improving GC treatment.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of Clinical Outcomes Between Billroth-I and Roux-en-Y Reconstruction Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-Matched Analysis.\",\"authors\":\"Yuma Ebihara, Noriaki Kyogoku, Hironobu Takano, Hideyuki Wada, Takeo Nitta, Daisuke Saikawa, Yoshiyuki Yamamura, Minoru Takada, Toshiaki Shichinohe, Satoshi Hirano\",\"doi\":\"10.1097/SLE.0000000000001411\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Gastric cancer (GC) is the third leading cause of cancer deaths, with surgery as the primary treatment; however, the outcomes of different types of surgeries still need to be understood further. This study evaluated the surgical outcomes and prognosis after minimally invasive distal gastrectomy (MIDG) for GC in a multicenter retrospective cohort using propensity score matching.</p><p><strong>Methods: </strong>This study retrospectively enrolled 688 patients who underwent curative MIDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into Billroth-I reconstruction (B-I) and Roux-en-Y (R-Y) reconstruction groups. Propensity score matching was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Surgical outcomes and prognoses were compared.</p><p><strong>Results: </strong>Three hundred propensity score-matched pairs were identified. The R-Y group had longer median operation time [309 (131 to 531) min vs. 265 (126 to 532) min; P<0.001], longer postoperative hospital stay [10 (5 to 110) d vs. 10 (5 to 43) d; P=0.042], and greater median blood loss (P=0.047) than the B-I group. Complications of Clavien-Dindo (CD) grade II (P<0.001) and grade III (P=0.027) were more frequent in the R-Y group than in the B-I group. Five-year overall survival (OS) was significantly higher in the B-I group than in the R-Y group (91.1% vs. 83.4%; P=0.019), whereas 5-year relapse-free survival (RFS) showed no significant difference between these 2 groups (P=0.056). Independent prognostic factors included reconstruction method, postoperative complications (≥CD III), and lymph node metastasis (pN) for OS and age (≥80), pT, and pN for RFS.</p><p><strong>Conclusions: </strong>Patients who underwent R-Y reconstruction had more frequent postoperative complications than those who underwent B-I reconstruction after MIDG. Although not significantly associated with RFS, these complications may affect OS. The findings of this study could help develop strategies for improving GC treatment.</p>\",\"PeriodicalId\":22092,\"journal\":{\"name\":\"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/SLE.0000000000001411\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SLE.0000000000001411","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
目的:胃癌(GC)是癌症死亡的第三大原因,手术是主要的治疗方法;然而,不同类型手术的结果仍需要进一步了解。本研究在多中心回顾性队列中采用倾向评分匹配法评估微创胃远端切除术(MIDG)治疗胃癌后的手术结果和预后。方法:本研究回顾性纳入了2018年1月至2024年12月在5家机构接受治疗性MIDG治疗GC的688例患者。患者分为Billroth-I重建组(B-I)和Roux-en-Y重建组(R-Y)。使用以下协变量进行倾向评分匹配:年龄、性别、体重指数、美国麻醉医师学会身体状况、淋巴结清扫程度、日本胃癌分期分类、新辅助化疗、辅助化疗。比较手术结果和预后。结果:确定了300个倾向分数匹配对。R-Y组中位手术时间更长[309 (131 ~ 531)min vs 265 (126 ~ 532) min;结论:行R-Y重建术的患者术后并发症发生率高于行B-I重建术的患者。这些并发症虽然与RFS无显著相关性,但可能影响OS。本研究结果可能有助于制定改善GC治疗的策略。
Comparison of Clinical Outcomes Between Billroth-I and Roux-en-Y Reconstruction Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-Matched Analysis.
Purpose: Gastric cancer (GC) is the third leading cause of cancer deaths, with surgery as the primary treatment; however, the outcomes of different types of surgeries still need to be understood further. This study evaluated the surgical outcomes and prognosis after minimally invasive distal gastrectomy (MIDG) for GC in a multicenter retrospective cohort using propensity score matching.
Methods: This study retrospectively enrolled 688 patients who underwent curative MIDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into Billroth-I reconstruction (B-I) and Roux-en-Y (R-Y) reconstruction groups. Propensity score matching was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Surgical outcomes and prognoses were compared.
Results: Three hundred propensity score-matched pairs were identified. The R-Y group had longer median operation time [309 (131 to 531) min vs. 265 (126 to 532) min; P<0.001], longer postoperative hospital stay [10 (5 to 110) d vs. 10 (5 to 43) d; P=0.042], and greater median blood loss (P=0.047) than the B-I group. Complications of Clavien-Dindo (CD) grade II (P<0.001) and grade III (P=0.027) were more frequent in the R-Y group than in the B-I group. Five-year overall survival (OS) was significantly higher in the B-I group than in the R-Y group (91.1% vs. 83.4%; P=0.019), whereas 5-year relapse-free survival (RFS) showed no significant difference between these 2 groups (P=0.056). Independent prognostic factors included reconstruction method, postoperative complications (≥CD III), and lymph node metastasis (pN) for OS and age (≥80), pT, and pN for RFS.
Conclusions: Patients who underwent R-Y reconstruction had more frequent postoperative complications than those who underwent B-I reconstruction after MIDG. Although not significantly associated with RFS, these complications may affect OS. The findings of this study could help develop strategies for improving GC treatment.
期刊介绍:
Surgical Laparoscopy Endoscopy & Percutaneous Techniques is a primary source for peer-reviewed, original articles on the newest techniques and applications in operative laparoscopy and endoscopy. Its Editorial Board includes many of the surgeons who pioneered the use of these revolutionary techniques. The journal provides complete, timely, accurate, practical coverage of laparoscopic and endoscopic techniques and procedures; current clinical and basic science research; preoperative and postoperative patient management; complications in laparoscopic and endoscopic surgery; and new developments in instrumentation and technology.